Evaluation of androgen-induced effects on the uptake of [18F]FDG, [11C]choline and [11C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model

被引:0
作者
Kimy M Emonds
Johannes V Swinnen
Evelyne Lerut
Michel Koole
Luc Mortelmans
Felix M Mottaghy
机构
[1] University Hospitals Leuven,Department of Nuclear Medicine
[2] Department of Oncology,Laboratory of Lipid Metabolism and Cancer
[3] KU Leuven,Department of Morphology and Molecular Pathology
[4] University Hospitals Leuven,Department of Nuclear Medicine
[5] University Hospital of Aachen,Department of Nuclear Medicine
[6] Maastricht University Medical Center,undefined
来源
EJNMMI Research | / 3卷
关键词
Prostate cancer; Androgen deprivation; PET; [; F]FDG; [; C]choline; [; C]acetate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 215 条
[1]  
Jemal A(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
[2]  
Siegel R(2005)2-[ Clin Cancer Res 11 4761-4769
[3]  
Xu J(2001)F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy Urology 57 108-111
[4]  
Ward E(1999)Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer Eur Urol 36 31-35
[5]  
Schoder H(2003)Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy Eur J Nucl Med Mol Imaging 30 607-611
[6]  
Herrmann K(2002)Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients Int J Cancer 98 19-22
[7]  
Gonen M(2003)Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Nuklearmedizin 42 25-30
[8]  
Hricak H(2004)Intraindividual comparison of [ Eur J Nucl Med Mol Imaging 31 1064-1072
[9]  
Eberhard S(2009)C]acetate and [11C]choline PET for detection of metastases of prostate cancer Nucl Med Commun 30 971-977
[10]  
Scardino P(2007)Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors BJU Int 100 786-793